re: Ann: Appendix 3Y- Change of Director'... muzz
you are way too negative imo
surely you know that small purchases from directors will do nothing in terms of driving the price direction. True the buying may be happening as a show of confidence on the merger but what is wrong with that? When they dont buy we complain, when the buy we complain
you mentioned in another post you have been holding for 8 years, and thus i understand your pain, however never in its history has BTA bene in a position where it can rgress a drug so far with none of its own funds to a level were annual revenue is likely to dwarf its market cap. Even settling with GSK for 100m is pittance vs the upside that is looking likely over the next few years
Add to My Watchlist
What is My Watchlist?